NCT02193022View on ClinicalTrials.gov

Miltefosine for Children With PKDL

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Post Kala Azar Dermal Leishmaniasis
Interventions
DRUG

Miltefosine

Trial Locations (1)

1212

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT02193022 - Miltefosine for Children With PKDL | Biotech Hunter | Biotech Hunter